Continuous Renal Replacement Therapy Market Projected to Gain Significant Value by 2027

Wilmington, Delaware, United States, Transparency Market Research Inc. The global continuous renal replacement therapy (CRRT) market was valued at ~US$ 865 Mn in 2018. It is projected to expand at a high CAGR of ~7% from 2019 to 2027.

Rise in acute kidney injury diseases, increase in patient pool, advancements in technology, growth in the geriatric population, surge in investments, and rising number of dialysis centers are likely to fuel the growth of the global continuous renal replacement therapy market.

Read Report Overview – https://www.transparencymarketresearch.com/continuous-renal-replacement-therapy-market.html

Continuous renal replacement therapy is used to treat acute kidney injury of hospitalized, critically-ill patients admitted in an ICU. Continuous renal replacement therapy is a preferred modality for managing the hemodynamic status of patients suffering from acute kidney injury.

Patients with acute renal failure and those experiencing complications such as imperfections or multiple organ failure in their circulatory systems, or cardiac that includes edema and cardiac insufficiency, are also treated using CRRT systems. Other complications where CRRT systems are used include postoperative liver failure, fulminant hepatitis, serve acute pancreatitis, and multiple organ failure.

Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10298

Increase in the rate of incidences of acute kidney injury, growing geriatric population with comorbidities, government focus on providing better healthcare facilities, rise in the prevalence of diabetes and hypertension associated with acute kidney injury, and increasing dialysis centers are expected to boost the global continuous renal replacement therapy market. As per research, 13.2 million people are affected with acute kidney injury globally each year, and acute kidney injury affects 13% to 18% of all patients admitted in hospitals in developed countries. These factors are expected to fuel the adoption of continuous dialysis for optimum care of patients.

Technological advancements are leading to the integration of new software to enhance continuous renal replacement treatment. Software integration has become an efficient tool for performing the treatment efficiently and accurately. Moreover, the acquisition of R&D units of emerging players to co-develop innovative technologies is anticipated to offer growth opportunities in the market.

Global Continuous Renal Replacement Therapy Market: Segment Analysis

The global continuous renal replacement therapy market has been segmented based on mode, product, therapy, end user, and region

Based on mode, the global continuous renal replacement therapy market has been categorized into slow continuous ultrafiltration (SCUF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), and continuous venovenous haemodiafiltration (CVVHDF). Among these, the continuous venovenous haemofiltration segment is projected to lead the global continuous renal replacement therapy market during the forecast period. The high market share of the continuous venovenous haemofiltration segment can be attributed to the acceptance of this technology by nephrologists, as it is more feasible than the other modes. This technology also incurs less complications than the other modes.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=10298

In terms of product, the global continuous renal replacement therapy market has been divided into dialysate & replacement fluids, disposables, and systems. The disposables segment is further classified into bloodline sets, hemofilters, and other disposables. The disposables segment is likely to dominate the global CRRT market, owing to the high volume sales of disposables and optimal usage of bloodline sets, hemofilters, and tubing in continuous dialysis procedures. The hemofilters sub-segment held the largest share of the disposables segment in 2018, and is expected to continue its dominance in the coming years.

On the basis of therapy, the global continuous renal replacement therapy market has been segmented into renal, non-renal, and combination. The renal segment accounted for the largest share of the global continuous renal replacement therapy market, and is expected to continue its dominance, owing to the optimum usage of CRRT machines for renal indication and availability of CRRT modalities. The combination segment is anticipated to grow at the highest rate, owing to a rise in the global geriatric population facing the risk of developing both, renal and non-renal indications.

Based on end user, the global continuous renal replacement therapy market has been classified into hospitals, clinics, and others. The hospitals segment dominated the global CRRT market in 2018, owing to well-established intensive care units in hospitals across the globe.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=10298

Global Continuous Renal Replacement Therapy Market: Regional Segmentation

In terms of region, the global continuous renal replacement therapy market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Europe dominated the global continuous renal replacement therapy market in 2018, owing to increase in incidences of acute kidney injury and favorable reimbursement policies. Moreover, the presence of key players in the region is driving the global continuous renal replacement therapy market. Well-established research & development industry, along with strong funding from governments for continuous renal replacement therapy in critically-ill patients is likely to boost market growth in the region.

The global continuous renal replacement therapy market in Asia Pacific is projected to expand at the highest CAGR during the forecast period, due to strong economic growth, rise in healthcare infrastructure, increase in geriatric population, and surge in investments for developing advanced CRRT products.

Initiatives by the local governments of countries in the region to attain self-sufficiency in manufacturing renal replacement devices are likely to propel the growth of the CRRT markets in Middle East & Africa and Latin America.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=10298

Global Continuous Renal Replacement Therapy Market: Major Players

Key players operating in the global continuous renal replacement therapy market include

  • Baxter International, Inc.
  • Nipro Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Medica SPA
  • INFOMED SA
  • Medtronic (Bellco Società unipersonale a r.l.)
  • Toray Medical Company Limited (Toray Industries, Inc.)​

These players are focused on adopting organic and inorganic growth strategies to strengthen their product portfolios to improve patient healthcare. Companies are focusing on increasing their geographical footprint, indulging in mergers & acquisitions, and investing in research & development in order to remain competitive in the global continuous renal replacement therapy market.

More Trending Reports by Transparency Market Research –

Dental Consumables Market: The global dental Consumables market was valued at US$ 23,718.0 Mn in 2018 and is anticipated to expand at a CAGR of 5.4% from 2019 to 2027.

Vascular Stents Market: The global vascular stents market is expected to grow at a moderate CAGR of ~5% during the forecast period.

Monopolar Electrosurgery Market: The global monopolar electrosurgery market was valued at US$ 1.72 Bn in 2018 and is anticipated to expand at a CAGR of 3.9% from 2019 to 2027.

Vertebroplasty and Kyphoplasty Market: The global vertebroplasty and kyphoplasty market was valued at US$ 1.0 Bn in 2018 and is anticipated to expand at a CAGR of 4.6% from 2019 to 2027.

Pulmonary Drug Delivery Devices Market: The global pulmonary drug delivery devices market is expected to exceed the value of US$ 49.5 Bn by the end of 2031.

Lactate Meter Market: The global lactate meter market is anticipated to reach more than US$ 299 Mn by the end of 2031.

Defibrillators Market: The global defibrillator market is expected to cross value of US$ 16.3 Bn by the end of 2031.

Hospital Acquired Disease Testing Market: The hospital acquired disease testing market analysis expects the market to develop at a CAGR of 14.7% during the forecast period, from 2019 to 2027.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Blog: https://tmrblog.com

Email: sales@transparencymarketresearch.com

 

Back to news